Literature DB >> 3042525

Increase of corneal graft survival by use of topically immunosuppressive agents in rabbits.

S Golubović1, B Z Radmanović.   

Abstract

Corneal graft survival in rabbits was significantly prolonged by topical treatment of the recipient eye with cyclophosphamide (0.1% in sterile isotonic NaCl) and methotrexate (0.1% in arachis oil) applied four times daily for 4 weeks. A control group of animals was treated with dexamethasone in the same way. The mean graft survival time was 52 +/- 18.5 days in the group treated with dexamethasone and 80 +/- 18.2 and 73 +/- 23.5, respectively, in the groups treated with cyclophosphamide and methotrexate. Cyclophosphamide and methotrexate applied topically produced no systemic side effects, and only one mild and transient local side effect in the form of hyperemia of the bulbar and palpebral conjunctiva. These two immunosuppressive drugs were more effective than the corticosteroid currently in clinical use, i.e., dexamethasone.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3042525     DOI: 10.1007/BF02181198

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  5 in total

1.  Lymphocytes and Langerhans cells in the normal human cornea.

Authors:  L Vantrappen; K Geboes; L Missotten; P C Maudgal; V Desmet
Journal:  Invest Ophthalmol Vis Sci       Date:  1985-02       Impact factor: 4.799

Review 2.  Antineoplastic drugs: clinical pharmacology and therapeutic use.

Authors:  R A Bender; L A Zwelling; J H Doroshow; G Y Locker; K R Hande; D S Murinson; M Cohen; C E Myers; B A Chabner
Journal:  Drugs       Date:  1978-07       Impact factor: 9.546

3.  Corneal graft rejection: a new rabbit model and cyclosporin-A.

Authors:  P A Hunter; A Garner; K R Wilhelmus; N S Rice; B R Jones
Journal:  Br J Ophthalmol       Date:  1982-05       Impact factor: 4.638

4.  [Effect of cyclophosphamide (Endoxan) on experimental arthritis in rabbits].

Authors:  K Chlud
Journal:  Z Rheumatol       Date:  1978 May-Jun       Impact factor: 1.372

5.  Cyclosporin A applied topically to the recipient eye inhibits corneal graft rejection.

Authors:  P A Hunter; K R Wilhelmus; N S Rice; B R Jones
Journal:  Clin Exp Immunol       Date:  1981-07       Impact factor: 4.330

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.